DLA Piper acts for Israel’s private equity fund Fortissimo Capital in acquisitions
Categories: Corporate and M&A, Hi-Tech, Investment Funds
DLA Piper advised leading Israeli private equity fund Fortissimo Capital on the acquisitions of an 85% majority stake of Sanquin Plasma Products B.V.,
the sole Dutch manufacturer of a broad range of medicines derived from blood plasma and Plasma Industries Belgium cvba-scrl, which provides solutions for the separation of blood plasma into proteins that improve the quality of life.